temafloxacin has been researched along with Bacterial Infections in 19 studies
*Bacterial Infections: Infections by bacteria, general or unspecified. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bridges, AJ; Culbertson, TP; Domagala, JM; Gambino, L; Hagen, SE; Karrick, G; Porter, K; Sanchez, JP; Sesnie, JA; Spense, FG | 1 |
Arakawa, S; Ban, Y; Hirose, T; Ito, Y; Kamidono, S; Kawada, Y; Kumamoto, Y; Kumon, H; Ohmori, H; Suzuki, K | 1 |
Deamer, RL; Heming, D; James, RE; Koenker, N; Prichard, JG | 1 |
Cho, N; Matsuda, S; Okada, H; Shimizu, T | 1 |
Goldstein, EJ | 1 |
Nix, DE; Symonds, WT | 1 |
Arakawa, S; Kamidono, S | 1 |
Almodovar, E; Burns, JJ; Qadri, SM; Rabea, N; Ueno, Y | 1 |
Parish, LC; Witkowski, JA | 1 |
Jungkind, DL; Parish, LC | 1 |
Childs, SJ; Cox, CE | 1 |
Pernet, AG | 1 |
Pankey, GA | 1 |
Acar, J; Baquero, F; Bergan, T; Forsgren, A; Phillips, I; Wiedemann, B | 1 |
Chu, DT; Clement, JJ; Hardy, DJ; Shipkowitz, NL; Swanson, RN | 1 |
4 review(s) available for temafloxacin and Bacterial Infections
Article | Year |
---|---|
Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Safety; Syndrome | 1996 |
Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Humans; Quinolones | 1992 |
Systemic management of cutaneous bacterial infections.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Quinolones; Skin Diseases, Infectious | 1991 |
Temafloxacin: an overview.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Prostatitis; Quinolones; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Infectious; Urinary Tract Infections | 1991 |
5 trial(s) available for temafloxacin and Bacterial Infections
Article | Year |
---|---|
[Re-examination of the criteria for clinical evaluation on bacterial prostatitis--analysis of the data of the clinical study of temafloxacin].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1994 |
[Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Bacterial Infections; Female; Fluoroquinolones; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Quinolones | 1993 |
Assessment of the UTI criteria for bacterial prostatitis in Japan.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones; Treatment Outcome | 1992 |
Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Skin Diseases, Infectious | 1991 |
Treatment of chronic bacterial prostatitis with temafloxacin.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Double-Blind Method; Fluoroquinolones; Humans; Male; Middle Aged; Prostatitis; Quinolones | 1991 |
10 other study(ies) available for temafloxacin and Bacterial Infections
Article | Year |
---|---|
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
Topics: Alkylation; Aminoquinolines; Animals; Anti-Bacterial Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydroxyquinolines; Mice; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Pyrrolidines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1991 |
Temafloxacin-induced hemolytic anemia and renal failure.
Topics: Acute Kidney Injury; Anemia, Hemolytic; Anti-Infective Agents; Bacterial Infections; Erythrocytes; Female; Fluoroquinolones; Hemolysis; Humans; Immune Complex Diseases; Middle Aged; Quinolones | 1993 |
Studies show new macrolide antibiotics to be superior to some older agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Quinolones | 1992 |
Oral temafloxacin approved for U.S. market.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Quinolones; United States; United States Food and Drug Administration | 1992 |
Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1992 |
Fluoroquinolones in the treatment of human infection: the role of temafloxacin.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Quinolones | 1991 |
Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
Topics: Age Factors; Aged; Anti-Infective Agents; Bacterial Infections; Drug Interactions; Female; Fluoroquinolones; Humans; Kidney Diseases; Male; Quinolones; Risk Factors; Sex Factors | 1991 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |
ESGAB breakpoint determination: temafloxacin.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones | 1991 |
Activity of temafloxacin against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gerbillinae; Gram-Positive Bacteria; Guinea Pigs; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1991 |